Hao, Meihua
Liu, Xishi
Guo, Sun-Wei
Article History
Received: 13 January 2022
Accepted: 9 May 2022
First Online: 4 June 2022
Declarations
:
: This study was approved by the Institutional Ethics Review Board of the Shanghai OB/GYN Hospital, Fudan University. All tissue samples were obtained after written, full and informed consent from recruited subjects.
: Not applicable.
: S.-W.G. provides consultancy advice for MSD R&D, Chugai Pharmaceutical Co., and BioHaven Pharmaceuticals. All other authors have no conflicts to declare.